KineMed

KineMed’s assay technology measures the flow of molecules through complex metabolic pathways and networks in living systems. The technology can be used to gain significant data safely from humans as well as from laboratory animals. KineMed’s technology is based on the premise that the operational unit of function in biology is neither the gene nor the protein, but is the flow of molecules through often-complex metabolic pathways. KineMed’s tests, called KineMarkers™, measure the flow of molecules through identified pathways responsible for health and disease. The proprietary KineMarker™ technology utilizes ultra sensitive mass spectrometry in concert with novel processes for labeling and measuring molecular fluxes in living organisms, including humans. KineMed has extensive intellectual property in molecular kinetics, with five currently issued and a significant number of pending patents. Although the processes and uses of KineMed’s technology are novel and proprietary, the underlying technology involving mass spectrometry is mature.